Schedule I and Schedule II drugs; adds various drugs to lists. (HB1440)
Introduced By
Del. Scott Garrett (R-Lynchburg)
Progress
✓ |
Introduced |
✓ |
Passed Committee |
✓ |
Passed House |
✓ |
Passed Senate |
☐ |
Signed by Governor |
☐ |
Became Law |
Description
Schedule I and Schedule II drugs. Adds MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) to Schedule I of the Drug Control Act and Dronabinol [(-)-delta-9-trans tetrahydrocannabinol] in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration to Schedule II of the Drug Control Act and removes naldemedine from Schedule II of the Drug Control Act. Read the Bill »
Status
02/28/2018: Passed the Senate
History
Date | Action |
---|---|
01/16/2018 | Committee |
01/16/2018 | Presented and ordered printed 18104387D |
01/16/2018 | Referred to Committee on Health, Welfare and Institutions |
01/17/2018 | Impact statement from VCSC (HB1440) |
01/23/2018 | Impact statement from VDH (HB1440) |
01/25/2018 | Reported from Health, Welfare and Institutions (22-Y 0-N) (see vote tally) |
01/25/2018 | Referred to Committee on Appropriations |
01/29/2018 | Assigned App. sub: Public Safety |
02/08/2018 | Subcommittee recommends reporting (8-Y 0-N) |
02/09/2018 | Reported from Appropriations (22-Y 0-N) (see vote tally) |
02/10/2018 | Read first time |
02/12/2018 | Read second time and engrossed |
02/13/2018 | Read third time and passed House BLOCK VOTE (100-Y 0-N) |
02/13/2018 | VOTE: BLOCK VOTE PASSAGE (100-Y 0-N) (see vote tally) |
02/14/2018 | Constitutional reading dispensed |
02/14/2018 | Referred to Committee on Education and Health |
02/22/2018 | Reported from Education and Health (15-Y 0-N) (see vote tally) |
02/22/2018 | Rereferred to Finance |
02/27/2018 | Reported from Finance with amendment (16-Y 0-N) (see vote tally) |
02/28/2018 | Constitutional reading dispensed (40-Y 0-N) (see vote tally) |
02/28/2018 | Read third time |
02/28/2018 | Reading of amendment waived |
02/28/2018 | Committee amendment agreed to |
02/28/2018 | Engrossed by Senate as amended |
02/28/2018 | Passed Senate with amendment (40-Y 0-N) (see vote tally) |
02/28/2018 | Senate amendment rejected by House (0-Y 94-N) |
02/28/2018 | VOTE: REJECTED (0-Y 94-N) (see vote tally) |
02/28/2018 | Senate insisted on amendment (40-Y 0-N) (see vote tally) |
02/28/2018 | Senate requested conference committee |
02/28/2018 | Placed on Calendar |
02/28/2018 | House acceded to request |
02/28/2018 | Conferees appointed by Senate |
02/28/2018 | Senators: Peake, Dunnavant, Locke |
02/28/2018 | Conferees appointed by House |
02/28/2018 | Delegates: Garrett, Orrock, Aird |
03/10/2018 | Failed to pass in House |
03/10/2018 | No further action taken |
03/10/2018 | Failed to pass |